OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3020% below fair value
$1.68+0.01 (+0.60%)
Close on Nov 13, 2026Market cap $1.25BP/E –Yield –
OPKO Health statistics
88 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 3.11
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 1.74
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 3.88%
- 10.8%
- Float
- 421M
- 49M
- Shares Held by Insiders
- 43.6%
- 11.7%
- Shares Held by Institutions
- 27.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 33M
- –
- Short Interest Change
- -3.41%
- -0.80%
- Short % of Float
- 7.80%
- 9.01%
- Short % of Shares Outstanding
- 4.40%
- 6.30%
- Days to Cover
- 9.23
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $1.86
- –
- 52-Week Low
- $0.98
- –
- 20-Day Moving Average
- $1.67
- –
- 50-Day Moving Average
- $1.60
- –
- 200-Day Moving Average
- $1.36
- –
- Average True Range (14)
- $0.08
- –
- Price Change (1 Week)
- -2.89%
- -1.15%
- Price Change (1 Month)
- 4.35%
- -4.87%
- Price Change (3 Months)
- 23.5%
- -21.0%
- Price Change (6 Months)
- 52.7%
- -20.6%
- Price Change (YTD)
- 33.3%
- -23.6%
- Price Change (1 Year)
- 27.3%
- -22.4%
- Price Change (3 Years)
- 20.9%
- -29.5%
- Price Change (5 Years)
- -59.2%
- -77.9%
- Price Change (10 Years)
- -83.8%
- -65.4%
- Average Volume (10 Days)
- 4M
- –
- Average Volume (20 Days)
- 3M
- –
- Average Volume (90 Days)
- 4M
- –
- Relative Volume
- 0.54
- 0.70
- Relative Strength Index (14)
- 54.6
- 43.4
- Volatility (1 Year)
- 57.1%
- 80.1%
- Beta (5 Years)
- 0.92
- 1.07
MarginsIndustry
- Pretax Margin
- -24.0%
- -11.6%
- EBITDA Margin
- -0.39%
- -27.7%
- FCF Margin
- -27.0%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -12.2%
- -49.9%
- Return on Assets (ROA)
- -7.64%
- -40.6%
- Return on Invested Capital (ROIC)
- -8.51%
- -32.9%
- Return on Capital Employed (ROCE)
- -5.12%
- -37.9%
Financial positionIndustry
- Current Ratio
- 4.97
- 3.30
- Quick Ratio
- 2.86
- 2.39
- Debt / Equity
- 0.00
- 0.49
GrowthIndustry
- Revenue Growth (YoY)
- -8.26%
- 6.82%
- Revenue Growth (3Y CAGR)
- -15.5%
- 2.25%
- Revenue Growth (5Y CAGR)
- -15.8%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.26
- 0.40
- Inventory Turnover
- 8.95
- 2.73
- Revenue Per Employee
- $220.50K
- $429.29K
- Profits Per Employee
- -$65.08K
- -$689.41K
- Employee Count
- 2,275
- 74
- WACC
- 9.70%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$120.51M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $381.28M
- $17.76M
- Net Cash Per Share
- $0.51
- $0.80
- Equity (Book Value)
- $1.12B
- $53.89M
- Book Value Per Share
- $1.50
- $1.50
- Tangible Book Value
- $402.64M
- $27.13M
- Working Capital
- $643.92M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$10.29M
- -$1.00M
- FCF Per Share
- -$0.18
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -11.8%
- -21.8%
- FCF Yield
- -10.8%
- -9.44%
- Buyback Yield
- 3.34%
- -0.76%
- Shareholder Yield
- 3.34%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- -$61.26M
- $2.90M
- Income Tax
- -$5.10M
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -0.28
- 0.23
- Piotroski F-Score
- 4
- 4
- Beneish M-Score
- -2.80
- -2.63
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | OPK | S&P 500 | Difference | OPK per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +27.3% | -3.0% | +30.3 pts | ||
| 3 months | +20.0% | -2.8% | +22.8 pts | ||
| Year to date | +33.3% | +11.5% | +21.8 pts | ||
| 1 year | +31.3% | +13.5% | +17.8 pts | ||
| 3 years | +31.3% | +77.7% | −46.4 pts | +9.5% | +21.1% |
| 5 years | -59.2% | +72.6% | −131.8 pts | -16.4% | +11.5% |
| 10 years | -82.2% | +308.2% | −390.4 pts | -15.9% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
33M OPK shares were sold short on Oct 30, 2026, down 3.4% from the previous report, or 7.80% of the shares available to trade. At recent volumes it would take 9.2 days to buy them back. Over the last 20 sessions, 53.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 32,849,261 | -3.4% | 3,557,224 | 9.2 |
| Oct 15, 2026 | 34,009,478 | -4.4% | 6,467,433 | 5.3 |
| Sep 30, 2026 | 35,560,259 | -1.2% | 2,379,498 | 14.9 |
| Sep 15, 2026 | 35,987,629 | +4.1% | 3,411,048 | 10.6 |
| Aug 31, 2026 | 34,558,372 | +2.7% | 2,509,994 | 13.8 |
| Aug 14, 2026 | 33,649,355 | +2.3% | 2,721,233 | 12.4 |
| Jul 31, 2026 | 32,883,700 | -2.3% | 6,096,772 | 5.4 |
| Jul 15, 2026 | 33,644,789 | +3.2% | 2,596,523 | 13.0 |
| Jun 30, 2026 | 32,594,765 | -0.6% | 3,649,836 | 8.9 |
| Jun 15, 2026 | 32,789,842 | -0.8% | 2,770,145 | 11.8 |
| May 29, 2026 | 33,037,706 | +1.2% | 3,027,312 | 10.9 |
| May 15, 2026 | 32,656,834 | -3.3% | 1,973,958 | 16.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?